Article Link: FDA Approves Aliqopa (copanlisib) for Adults with Relapsed Follicular Lymphoma Source: FDA New Drug Approvals
Actelion Receives FDA Approval of Tracleer (bosentan) for Use in Pediatric Patients with Pulmonary Arterial Hypertension
Article Link: Actelion Receives FDA Approval of Tracleer (bosentan) for Use in Pediatric Patients with Pulmonary Arterial Hypertension ...
FDA Approves Mylotarg (gemtuzumab ozogamicin) for the Treatment of Acute Myeloid Leukemia
Article Link: FDA Approves Mylotarg (gemtuzumab ozogamicin) for the Treatment of Acute Myeloid Leukemia Source: FDA New Dru...
FDA Approves Genentech’s Actemra (tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Article Link: FDA Approves Genentech’s Actemra (tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome ...
Teva Announces FDA Approval of Austedo (deutetrabenazine) Tablets for the Treatment of Tardive Dyskinesia in Adults
Article Link: Teva Announces FDA Approval of Austedo (deutetrabenazine) Tablets for the Treatment of Tardive Dyskinesia in Adults ...
FDA Approves Kymriah (tisagenlecleucel) CAR-T Gene Therapy for Acute Lymphoblastic Leukemia
Article Link: FDA Approves Kymriah (tisagenlecleucel) CAR-T Gene Therapy for Acute Lymphoblastic Leukemia Source: FDA New D...
FDA Approves Vabomere (meropenem and vaborbactam) for Complicated Urinary Tract Infections
Article Link: FDA Approves Vabomere (meropenem and vaborbactam) for Complicated Urinary Tract Infections Source: FDA New Dr...
FDA Approves Benznidazole as First U.S. Treatment for Chagas Disease
Article Link: FDA Approves Benznidazole as First U.S. Treatment for Chagas Disease Source: FDA New Drug Approvals
FDA Approves Cyltezo (adalimumab-adbm), a Biosimilar to Humira
Article Link: FDA Approves Cyltezo (adalimumab-adbm), a Biosimilar to Humira Source: FDA New Drug Approvals
Faslodex (fulvestrant) Receives FDA Approval as Monotherapy for Expanded Use in HR+, HER2- Advanced Breast Cancer
Article Link: Faslodex (fulvestrant) Receives FDA Approval as Monotherapy for Expanded Use in HR+, HER2- Advanced Breast Cancer ...